CONSOLIDATED STATEMENTS OF EQUITY - USD ($)	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Non-controlling Interest	Series A Preferred Preferred stock	Series C Preferred Preferred stock
Beginning balance (in shares) at Dec. 31, 2017		32,658,176				453,567	31,568
Beginning balance at Dec. 31, 2017	$ 28,384,358	$ 32,658	$ 67,768,509	$ (39,816,300)	$ 399,005	$ 454	$ 32
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share based compensation expense, total	145,971		145,971
Conversion of Series B1 Preferred stock to common (in shares)		500,000
Conversion of Series B1 Preferred stock to common	595,563	$ 500	779,500	(184,437)
Dividends on Series B and B1	(554,917)			(554,917)
Accretion of discount on Series B and B1	(457,853)			(457,853)
Net income (loss)	(2,208,083)			(2,258,622)	50,539
Ending balance (in shares) at Mar. 31, 2018		33,158,176				453,567	31,568
Ending balance at Mar. 31, 2018	25,905,039	$ 33,158	68,693,980	(43,272,129)	449,544	$ 454	$ 32
Beginning balance (in shares) at Dec. 31, 2017		32,658,176				453,567	31,568
Beginning balance at Dec. 31, 2017	$ 28,384,358	$ 32,658	67,768,509	(39,816,300)	399,005	$ 454	$ 32
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of options to common (in shares)	241
Adjustment of carrying mount of non-controlling interest	$ 0
Net income (loss)	(1,940,129)
Ending balance (in shares) at Sep. 30, 2018		38,840,890				419,859	0
Ending balance at Sep. 30, 2018	27,878,128	$ 38,841	72,974,146	(46,366,609)	1,231,330	$ 420	$ 0
Beginning balance (in shares) at Mar. 31, 2018		33,158,176				453,567	31,568
Beginning balance at Mar. 31, 2018	25,905,039	$ 33,158	68,693,980	(43,272,129)	449,544	$ 454	$ 32
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of options to common (in shares)		241
Exercise of options to common	0
Share based compensation expense, total	183,750		183,750
Conversion of Series A Preferred stock to common (in shares)		33,708				(33,708)
Conversion of Series A Preferred stock to common	0	$ 34				$ (34)
Conversion of Series B Preferred stock to common (in shares)		32,149
Conversion of Series B Preferred stock to common	62,962	$ 33	99,629	(36,700)
Conversion of Series B1 Preferred stock to common (in shares)		133,264
Conversion of Series B1 Preferred stock to common	159,203	$ 133	207,759	(48,689)
Dividends on Series B and B1	(534,680)			(534,680)
Accretion of discount on Series B and B1	(470,825)			(470,825)
Net income (loss)	2,661,804			2,530,068	131,736
Ending balance (in shares) at Jun. 30, 2018		33,357,538				419,859	31,568
Ending balance at Jun. 30, 2018	27,967,253	$ 33,358	69,185,118	(41,832,955)	581,280	$ 420	$ 32
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Correction of non-controlling interest	0			101,718	(101,718)
Share based compensation expense, total	165,058		165,058
Fixed assets contributed capital VRMLA	857,738				857,738
Conversion of Series C Preferred stock to common (in shares)		3,156,800					(31,568)
Conversion of Series C Preferred stock to common	0	$ 3,157	(3,125)				$ (32)
Conversion of Series B1 Preferred stock to common (in shares)		2,326,552
Conversion of Series B1 Preferred stock to common	2,992,151	$ 2,326	3,627,095	(637,270)
Dividends on Series B and B1	(1,194,524)			(1,194,524)
Accretion of discount on Series B and B1	(515,698)			(515,698)
Net income (loss)	(2,393,850)			(2,287,880)	(105,970)
Ending balance (in shares) at Sep. 30, 2018		38,840,890				419,859	0
Ending balance at Sep. 30, 2018	27,878,128	$ 38,841	72,974,146	(46,366,609)	1,231,330	$ 420	$ 0
Beginning balance (in shares) at Dec. 31, 2018		40,174,821				419,859
Beginning balance at Dec. 31, 2018	28,809,044	$ 40,175	75,131,122	(47,800,886)	1,438,213	$ 420
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share based compensation expense, total	143,063		143,063
Conversion of Series B1 Preferred stock to common (in shares)		96,160
Conversion of Series B1 Preferred stock to common	119,768	$ 96	149,914	(30,242)
Dividends on Series B and B1	(406,795)			(406,795)
Accretion of discount on Series B and B1	(530,433)			(530,433)
Net income (loss)	(5,068,995)			(4,963,564)	(105,431)
Ending balance (in shares) at Mar. 31, 2019		40,270,981				419,859
Ending balance at Mar. 31, 2019	23,065,652	$ 40,271	75,424,099	(53,731,920)	1,332,782	$ 420
Beginning balance (in shares) at Dec. 31, 2018		40,174,821				419,859
Beginning balance at Dec. 31, 2018	$ 28,809,044	$ 40,175	75,131,122	(47,800,886)	1,438,213	$ 420
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of options to common (in shares)	78,425
Adjustment of carrying mount of non-controlling interest	$ 970,809
Net income (loss)	(6,857,643)			(6,500,000)
Ending balance (in shares) at Sep. 30, 2019		41,849,406				419,859
Ending balance at Sep. 30, 2019	20,780,014	$ 41,850	79,719,745	(59,788,939)	806,938	$ 420
Beginning balance (in shares) at Mar. 31, 2019		40,270,981				419,859
Beginning balance at Mar. 31, 2019	23,065,652	$ 40,271	75,424,099	(53,731,920)	1,332,782	$ 420
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of options to common (in shares)		75,925
Exercise of options to common	4,500	$ 76	4,424
Share based compensation expense, total	171,002		171,002
Dividends on Series B and B1	(412,875)			(412,875)
Accretion of discount on Series B and B1	(532,925)			(532,925)
VRM LA distribution	(285,534)				(285,534)
Net income (loss)	(629,765)			(427,436)	(202,329)
Ending balance (in shares) at Jun. 30, 2019		40,346,906				419,859
Ending balance at Jun. 30, 2019	21,380,055	$ 40,347	75,599,525	(55,105,156)	844,919	$ 420
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of options to common (in shares)		2,500
Exercise of options to common	2,575	$ 3	2,572
Share based compensation expense, total	159,426		159,426
Dividends on Series B and B1	(419,096)			(419,096)
Accretion of discount on Series B and B1	(550,774)			(550,774)
Adjustment of carrying mount of non-controlling interest	970,809		970,809
Accretion of redeemable non-controlling interest to redemption value	(1,849,930)			(1,849,930)
Issuance of common stock and warrants (in shares)		1,500,000
Issuance of common stock and warrants	2,216,711	$ 1,500	2,987,413	(772,202)
Net income (loss)	(1,158,883)			(1,091,781)
Net loss					(37,981)
Net loss	(1,129,762)
Ending balance (in shares) at Sep. 30, 2019		41,849,406				419,859
Ending balance at Sep. 30, 2019	$ 20,780,014	$ 41,850	$ 79,719,745	$ (59,788,939)	$ 806,938	$ 420